PCRX- Pacira Biosciences, Inc.
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.06M | - | |
| Other | 218.9K | $4.97M | - | |
| Other | 167.1K | $3.79M | -10,259 | |
| CFO | 118.3K | $2.69M | - | |
| VP | 62.3K | $1.41M | -6,115 |
Activity
Buys and sells only
Transactions
10 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | Hastings Paul J77 | Director | Sale+OE | 7,000 | $41.85 | $292,950.00 | -49.4% | -13.6% | -27.4% | |
| May 11, 2023 | Pace Gary W66 | Director | Sale+OE | 5,015 | $41.78 | $209,526.70 | -3.5% | -9.4% | -30.0% | |
| Apr 3, 2023 | Brege Laura62 | Director | Sale+OE | 7,000 | $40.72 | $285,040.00 | -40.8% | -3.1% | -31.1% | |
| Jan 5, 2023 | Molloy Anthony74 | Chief Lgl &Compliance Officer | Sell | 704 | $38.49 | $27,093.95 | -1.8% | +6.2% | -11.0% | |
| Oct 7, 2022 | Reinhardt Max79 | President, Rest Of World | Sell | 1,380 | $58.00 | $80,040.00 | -4.2% | -31.6% | -47.1% | |
| Aug 3, 2022 | Winston Roy68 | Chief Medical Officer | Sell | 476 | $55.70 | $26,513.20 | -1.0% | -9.4% | -33.1% | |
| Aug 3, 2022 | Slonin Jonathan72 | Chief Clinical Officer | Sell | 308 | $55.70 | $17,155.60 | -0.8% | -9.4% | -33.1% | |
| Jul 11, 2022 | Hastings Paul J77 | Director | Sell | 533 | $56.95 | $30,354.35 | -6.9% | -0.4% | -33.7% | |
| Jul 5, 2022 | Slonin Jonathan72 | Chief Clinical Officer | Sell | 924 | $57.19 | $52,841.71 | -2.4% | -5.6% | -33.5% | |
| Jun 8, 2022 | Stack David M67 | CEO And Chairman | Sell | 25,793 | $60.56 | $1,561,998.17 | -3.4% | -13.7% | -37.7% |